Pricing Log in Create free account

Novogen Limited (KZIA) vs Polaryx Therapeutics, Inc. (PLYX)

Novogen Limited and Polaryx Therapeutics, Inc. are both Biotechnology companies. Novogen Limited and Polaryx Therapeutics, Inc. are of similar size ($92.4M and $89.7M). Across the 7 metrics below, Novogen Limited leads on 4 and Polaryx Therapeutics, Inc. on 3.

Valuation

Metric KZIA PLYX Biotechnology median
P/E n/m n/m 10.26
P/S — n/m 9.18
P/B n/m 7.94 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 1.46 n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (3.03%) (12.03%) (34.89%)
Free cash flow yield 0.00% (9.48%) (24.52%)

Profitability

Metric KZIA PLYX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (50.12%)
Return on assets 0.00% (169.05%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KZIA PLYX Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 63.24% 77.72% 29.88%
Revenue growth, 5-year CAGR 11.56% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric KZIA PLYX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.87 13.53 4.89
Net debt to EBITDA 0.30 0.66 1.01

Dividend

Metric KZIA PLYX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KZIA PLYX Biotechnology median
Market cap 92.35m 89.72m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack